Gilead to pay $12 Billion for Kite Pharma

04.09.2017 - US drugmaker Gilead Sciences has agreed to pay almost $12 billion to acquire compatriot Kite Pharma. Through the cash transaction, it will gain access to Car-T, Kite’s cutting-edge...